fbpx
Biomed Israel 2023: The 21th National Life Science & Technology Week • May 16-18, 2023 | David InterContinental • Tel Aviv, Israel

Day 1

TUESDAY, MAY 10

09:00 - 09:15Welcome by Conference Chairpersons:
Ruti Alon, Founder and CEO, Medstrada
Ora Dar, PhD, Senior Expert, Medical Sciences and Health Innovation
Nissim Darvish, MD, PhD, Managing General Partner, MeOHR Ventures
09:15 - 09:30Coffee Break
HALL A
09:30 - 14:00CELL, GENE AND NUCLEIC ACIDS THERAPIES - THE NEXT FRONTIER IN HUMAN HEALTH
11:00 - 11:30Coffee Break
Chairpersons: Erez Chimovits, Orbimed Partner, Private Equity, Rami Skaliter, PhD, CEO, Cell Cure Neurosciences
09:30 - 09:40Opening Remarks: Erez Chimovits, Orbimed Partner, Private Equity
09:40 - 10:00Sumant Ramachandra, MD, PhD, President and CEO, ImmPACT Bio, "Autologous CAR-T based therapies," "ZOOM"
10:00 - 10:20Chen Schor, President and CEO, Adicet Bio, "Allogeneic CAR-T based therapies"
10:20-10:35
Noam Pilpel, PhD, CTO, Gilboa Therapeutics
10:35 - 10:55Zhen Li, PhD, President and CEO, ADARx Pharmaceuticals, "Oligonucleotide therapeutics"
11:30 - 11:45
Gili Hart, CEO, Splisense
11:45 - 12:05Adel Nada, MD, Co-founder and CEO, GentiBio, "T-regs for curing autoimmunity"
12:05 - 12:25David Baram, PhD, President and CEO, Emendo Biotherapeutics, "Gene editing based therapies"
12:25 - 12:45
Michal Golan Mashiach, PhD, Founder and CEO, EdiTy Therapeutics
12:45 - 13:00Rami Skaliter, PhD, CEO, Cell Cure Neurosciences, "Embrionic stem cells therapies"
13:00 - 13:15
Yona Geffen, PhD, VP, R&D, Gamida Cell
13:15 - 13:30Noam Diamant, PhD, Co-founder and CEO, Noga Therapeutics
13:30 - 13:45Adi Elkeles, PhD, Founder and CEO, Trobix Bio
13:45 - 14:00Prof. Dror Mevorach, MD, CSO, Enlivex Therapeutics, "Allocetra-OTS: High synergistic effectiveness against solid tumor with immune check point inhibitors or CAR T."
14:00 - 15:00Lunch Break
HALL B
09:30 - 14:00MEDICAL DEVICE - BREAKTHROUGH TECHNOLOGIES
11:00 - 11:30Coffee Break
Chairperson: Eyal Lifschitz, Co-founder and General Managing Partner, Peregrine Ventures
09:30 - 09:45David Rigler, VP Clinical Research and Regulatory Affairs, Nano Retina
09:45 - 10:00Ronen Eckhouse, Co-founder and CEO, Rapid Medical
10:00 - 10:15Amir Danino, Founder and CEO, Innoventric
10:15 - 10:30Shlomit Chappel-Ram, PhD, VP, R&D, Digma Medical
10:30 - 10:45Yotam Drechsler, CEO and Co-founder, BrainQ Technologies
10:45 - 11:05Daniel Goldstein, PhD, Advocate and Patent Attorney, Sanford T. Colb & Co., "Ecosystems and homeostasis: A law and technology look at the field of medical devices"
11:30 - 11:45Ronen Segal, CTO, Alpha Tau Medical
11:45 - 12:00Avner Geva, Founder and CEO, Vensica Therapeutics
12:00 - 12:15Idan Geva, CEO,
12:15 - 12:35Joseph (Joe) Smith, MD, PhD, CSO, Becton Dickinson, "BD - Innovation at Scale"
12:35 - 12:50Benny Dilmoney, CEO, Magneto Thrombectomy Solutions
12:50 - 13:05Gilad Marom, CEO, Restore Medical
13:05 - 13:20Dvir Cohen, CEO and President, Memic Innovative Surgery
13:20 - 13:30Closing Remarks: Eyal Lifschitz, Co-founder and General Managing Partner, Peregrine Ventures
13:30 - 13:50Sandra Morgan, Board Director and Advisor, Healthcare, Pharmaceutical, and Technology, "MedTech 2032: The Future"
14:00 - 15:00Lunch Break
HALL C
09:30-14:00BIO FOOD - NEW ERA OF FOOD TECHNOLOGIES; ITS IMPACT ON NUTRITION AND HEALTH
11:00 - 11:30Coffee Break
Chairperson: Tammy Meiron, PhD, CTO, Fresh Start FoodTech Incubator
09:30 - 09:55Valerio Nanninni, General Manager, Novozymes Advanced Proteins Solutions, "The food industry perspective and the adaptation of bio-tech technologies"
09:55 - 10:20Matthew Robin, CEO, Mifloma Group-at Migros Industries, "The perspective of a leading FoodTech company, entering the Bio Food arena"
10:20 - 10:45Prof. Yaakov Nahmais, PhD, Founder and President, Future Meat Technologies, "The evolution of a Bio Food Company in the eye of an academic researcher"
10:45 - 11:00Ilan Samish, Phd, Founder and CEO, Amai Proteins
11:30 - 11:55Prof. Eldad Tzahor, PhD, Co-founder and scientific advisor, Profuse Tech, "Bioconversion - the Case Study of Profuse"
11:55 - 12:20Miriam Guggenheim, Co-chair, Covington’s Israel International Initiative, "Regulatory barriers and challenges in adaptation of bio-tech platforms into foods"
12:20 - 12:35Tal Lutzky, Co-founder and CEO, Pigmentum
12:35 - 12:50Neta Lavon, PhD, CTO, Aleph Farm
12:50 - 13:05Orna Harel, PhD, Co-founder and CEO, Sea 2 Cell
13:05 - 13:20Tsipi Shoham, PhD, Co-founder and CEO, GreenOnyx
13:20 - 13:35Iftach Nachman, PhD, Co-founder and Scientific Advisor, Forsea
13:35 - 13:50Fabian Trumper, Co-founder and CEO, Bountica
13:50 - 14:05Prof. Nurit Argov-Argaman, PhD, CTO, Wilk
14:00 - 15:00Lunch Break
PLENARY SESSION
15:15 - 15:45Mikael Dolsten, MD, PhD, Chief Scientific Officer and President, "ZOOM"
Fireside Chat with: Gil Bar-Nahum, PhD, Managing Director, Jefferies International, UK
15:45 - 16:15Robert Cohen, MS, President, Digital, Robotics, and Enabling Technology, Stryker, "Orthopedic industry and clinical insights - AI and predictive analytics," "ZOOM"
16:15 - 16:45Gil Bar-Nahum, PhD, Managing Director, Jefferies International, UK, "The State of Life Sciences Industry, Today and Tomorrow"
16:45 - 17:15Sandra Morgan, Board Director and Advisor, Healthcare, Pharmaceutical, and Technology, "Trials and Tribulations on the Riad to Marketing and Selling your Products to the USA Healthcare System"
17:30 - 20:00Gala Event